TAILIEUCHUNG - Complementary and Alternative Medicine in Back Pain Utilization Report

Before embarking on policy reforms to improve access, national policy-makers need to have a clear understanding of the factors that are contributing to high prices and poor avail- ability; this will help ensure that their response is tailored to the national context. Table lists a number of possible policy options and specific actions that are open to governments for reducing prices and improving availability. The most appropriate response will likely be multi-faceted and will vary depending on the sector, whether the medicine is imported or locally manufactured and whether it is a single-source originator brand product or a multi- source generic. | Evidence Report Technology Assessment Number 177 Complementary and Alternative Medicine in Back Pain Utilization Report Prepared for Agency for Healthcare Research and Quality . Department of Health and Human Services 540 Gaither Road Rockville MD 20850 http Contract No. 290-02-0020 Prepared by McMaster University Evidence-based Practice Center Hamilton Ontario Canada EPC Director Parminder Raina . Principal Investigators P. Lina Santaguida . . Anita Gross . . Clin Epi Authors P. Lina Santaguida . . Anita Gross . . Clin. Epi. Jason Busse . . Joel Gagnier . . . KathrynWalker . Mohit Bhandari . . . Parminder Raina . . AHRQ Publication No. 09-E006 February 2009 This document is in the public domain and may be used and reprinted without permission except those copyrighted materials noted for which further reproduction is prohibited without the specific permission of copyright holders. Suggested Citation Santaguida PL Gross A Busse J Gagnier J Walker K Bhandari M Raina P. Evidence Report on Complementary and Alternative Medicine in Back Pain Utilization Report. Evidence Report Technology Assessment No. 177. Prepared by the McMaster University Evidence-based Practice Center under Contract No. 290-02-0020. AHRQ Publication Rockville MD. Agency for Healthcare Research and Quality. February 2009. No investigators have any affiliations or financial involvement . employment consultancies honoraria stock options expert testimony grants or patents received or pending or royalties that conflict with material presented in this report. ii Preface The Agency for Healthcare Research and Quality AHRQ through its Evidence-Based Practice Centers EPCs sponsors the development of evidence reports and technology assessments to assist public- and private-sector organizations in their efforts to improve the quality of healthcare in the United States. The

• Y học thường thức
• sector availability
• originator brand medicines
• generic products ranged
• Germin Gene Products
• Under Salt Stress
• Adaptation and Tolerance
• medicine availability
• private sector
• private pharmacies
• Insulin Like Growth
• Based Approach
• New Therapeutics
• non adherent sometimes
• assess adherence
• dispense and review
• policy options are available
• equitable and sustainable
• Regulatory Mechanism
• Asexual Cycles
• Terpenoids and Gibberellic
• Acids Interaction
• individual patients
• information accessible
• prescribed medicines
• generic products range
• Proteins and Enzymes
• Post Translational
• Nuclear Proteins
• Planning Incorporation
• Ethics of Industry
• Alliance with Health
• Promoting Charities
• Poland – Organization
• Availability and Space
• Mammary gland development
• defined population